SCHEMBL29942349

SCHEMBL29942349

Cc1n[nH]c2ccc(-c3cccnc3)cc12

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAP2K4 P45985 1/20 0.64
DYRK1A Q13627 14/20 0.62
CLK2 P49760 5/20 0.62
CDK7 P50613 2/20 0.62
LRRK2 Q5S007 2/20 0.62
CHEK1 O14757 1/20 0.62
AURKA O14965 1/20 0.62
DAPK3 O43293 1/20 0.62
JAK2 O60674 1/20 0.62
PRKD3 O94806 1/20 0.62
MAP4K4 O95819 1/20 0.62
PAK4 O96013 1/20 0.62
ABL1 P00519 1/20 0.62
LCK P06239 1/20 0.62
FYN P06241 1/20 0.62
CSF1R P07333 1/20 0.62
RET P07949 1/20 0.62
IGF1R P08069 1/20 0.62
MET P08581 1/20 0.62
PDGFRB P09619 1/20 0.62

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10213963 0.84 JAK2 (0.69) MAP2K4DYRK1ACLK2CDK7LRRK2
SCHEMBL30588952 0.84 JAK2 (0.69) MAP2K4DYRK1ACLK2CDK7LRRK2
SCHEMBL5514698 0.84 MKNK1 (0.72) MAP2K4DYRK1ACLK2CDK7LRRK2
SCHEMBL27968550 0.83 MKNK1 (0.71) MAP2K4DYRK1ACLK2CDK7CHEK1
SCHEMBL14689480 0.79 PIM1 (0.78) DYRK1ACLK2PIM1CLK3
SCHEMBL16284624 0.78 TLR8 (0.59) DYRK1ACLK2CDK7LRRK2CHEK1
SCHEMBL19188029 0.78 JAK2 (0.57) MAP2K4DYRK1ACLK2LRRK2DAPK3
SCHEMBL22819364 0.78 MAP2K4 (1.00) MAP2K4DYRK1ACLK2LRRK2PIM1
SCHEMBL12907433 0.78 MKNK1 (0.51) MAP2K4DYRK1ACDK7CHEK1JAK2
SCHEMBL760763 0.77 DYRK1A (0.65) MAP2K4DYRK1ACLK2CDK7LRRK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11446398-B2 Regulated biocircuit systems OBSIDIAN THERAPEUTICS, INC. (US) 2022-09-20 US disclosed